🔎 Trials Near Me

Gara Jalqabaatti › Hidradenitis Suppurativa › Arizona › Phoenix

Qorannoo klinikaalii Hidradenitis Suppurativa Phoenix, AZ keessatti

Qorannoo 5 Hidradenitis Suppurativa f Phoenix fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

Namoota walitti qabaa jiraSadarkaa 1
  • Saguaro Dermatology, Phoenix
Umuriin 12 hanga 75 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07049575

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

Namoota walitti qabaa jiraSadarkaa 3
  • Investigative Site US004, Phoenix
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06855498

Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

Namoota walitti qabaa jiraSadarkaa 2
  • Medical Dermatology Specialists - Site Number: 8400019, Phoenix
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07170917

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Namoota walitti qabaa jiraSadarkaa 2
  • Medical Dermatology Specialists Phoenix, Phoenix
  • Saguaro Dermatology, Phoenix
Umuriin 12 hanga 17 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07213973

A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

Namoota walitti qabaa jiraSadarkaa 2
  • Medical Dermatology Specialist, Phoenix
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT07384975

Qorannoo Hidradenitis Suppurativa magaalota biroo keessatti

Qorannoo biroo Phoenix keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.